Register Login

Milestone Pharmaceuticals Inc (MIST)

  • SEC News
  • Aug. 12, 2025, 11:17 UTC
  • 4
  • 0 comments

New Form 8-K - Milestone Pharmaceuticals Inc. Filed: 2025-08-12 AccNo: 0001104659-25-076468 Size: 288 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Comment Full text

TScan Therapeutics Inc. (TCRX)

  • SEC News
  • Aug. 12, 2025, 11:16 UTC
  • 3
  • 0 comments

New Form 8-K - TScan Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0000950170-25-106915 Size: 424 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Comment Full text

Eliem Therapeutics Inc (ELYM)

  • SEC News
  • Aug. 12, 2025, 11:11 UTC
  • 3
  • 0 comments

New Form 8-K - Climb Bio, Inc. Filed: 2025-08-12 AccNo: 0000950170-25-106913 Size: 361 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Comment Full text

Altimmune Inc (ALT)

  • SEC News
  • Aug. 12, 2025, 11:11 UTC
  • 3
  • 0 comments

New Form 8-K - Altimmune, Inc. Filed: 2025-08-12 AccNo: 0001558370-25-011145 Size: 381 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Comment Full text

Centessa Pharmaceuticals plc (CNTA)

  • SEC News
  • Aug. 12, 2025, 11:08 UTC
  • 3
  • 0 comments

New Form 8-K - Centessa Pharmaceuticals plc Filed: 2025-08-12 AccNo: 0001847903-25-000133 Size: 383 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Comment Full text

Adverum Biotechnologies Inc (ADVM)

  • SEC News
  • Aug. 12, 2025, 11:03 UTC
  • 5
  • 0 comments

New Form 8-K - Adverum Biotechnologies, Inc. Filed: 2025-08-12 AccNo: 0001628280-25-039759 Size: 222 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Comment Full text

Search

News categories